Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current Assets    
Cash $ 7,472,224 $ 2,194,850
Accounts receivable, net 18,179,933 10,537,395
Factor receivables, net 0 807,648
Inventory 38,432,012 8,915,345
Prepaid and other current assets 786,036 1,003,774
Subscription receivable 0 837,025
Total Current Assets 64,870,205 24,296,037
Other Assets    
Property and equipment, net 13,341,629 3,066,924
Other assets 742,691 127,733
Total Assets 78,954,525 27,490,694
Current Liabilities    
Accounts payable 14,440,506 6,955,218
Accrued expenses 1,815,567 598,473
Factor loan payable 0 590,950
Warrant liabilities 4,801,929 0
Total Current Liabilities 21,058,002 8,144,641
Total Liabilities 21,058,002 8,144,641
Shareholders' Equity    
Common stock, $0.0001 par value, 200,000,000 shares authorized, 129,299,607 and 43,918,831 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively 12,930 4,392
Additional paid-in capital 156,171,483 80,103,653
Accumulated deficit (98,287,890) (60,761,992)
Total Shareholders' Equity 57,896,523 19,346,053
Total Liabilities and Shareholders' Equity 78,954,525 27,490,694
Series C Preferred Stock [Member]    
Shareholders' Equity    
Preferred Stock 0 0
Series D Preferred Stock [Member]    
Shareholders' Equity    
Preferred Stock 0 0
Series E Preferred Stock [Member]    
Shareholders' Equity    
Preferred Stock $ 0 $ 0